Analysts at Credit Suisse Maintained their Past ‘”Outperform”’ rating on Shares Humana (NYSE:HUM), Set a $390 Target

November 9, 2018 - By Jeanette Garcia

Humana Inc. (NYSE:HUM) Logo

Investors sentiment increased to 1.02 in 2018 Q2. Its up 0.24, from 0.78 in 2018Q1. It improved, as 22 investors sold Humana Inc. shares while 215 reduced holdings. 56 funds opened positions while 186 raised stakes. 121.65 million shares or 0.51% less from 122.28 million shares in 2018Q1 were reported.

167,100 are owned by Waddell Reed Financial. Polar Cap Llp holds 240,436 shares. Marshall Wace Limited Liability Partnership has 0.09% invested in Humana Inc. (NYSE:HUM). Plante Moran Advsrs Ltd Co holds 0.06% of its portfolio in Humana Inc. (NYSE:HUM) for 417 shares. Moreover, Columbus Hill Capital Mngmt L P has 3.19% invested in Humana Inc. (NYSE:HUM) for 150,759 shares. Fdx Inc invested 0.02% of its portfolio in Humana Inc. (NYSE:HUM). Brinker Cap holds 0.03% or 2,527 shares in its portfolio. Retirement Of Alabama has 64,570 shares for 0.09% of their portfolio. Earnest Prtn Ltd holds 0.37% or 132,380 shares in its portfolio. 137,928 are owned by Pension Ser. Proshare Lc holds 0.05% or 23,384 shares. Hsbc Holdings Plc invested 0.17% of its portfolio in Humana Inc. (NYSE:HUM). Federated Investors Pa owns 19,288 shares or 0.02% of their US portfolio. Weiss Multi has 26,355 shares for 0.19% of their portfolio. Fort Washington Invest Advsr Oh, Ohio-based fund reported 1,400 shares.

Since June 4, 2018, it had 0 insider purchases, and 9 selling transactions for $34.47 million activity. Another trade for 24,182 shares valued at $7.40M was sold by HUNTER CHRISTOPHER H.. Zipperle Cynthia H sold $306,005 worth of Humana Inc. (NYSE:HUM) on Wednesday, June 13. The insider Bierbower Elizabeth D sold 3,092 shares worth $1.02M. 27,461 shares valued at $8.42 million were sold by BILNEY JODY L on Friday, June 15. 15,637 shares valued at $4.58M were sold by Fleming William Kevin on Monday, June 4. The insider LeClaire Brian P. sold $1.58 million.

Humana (NYSE:HUM) Rating Reaffirmed

New York: In a research note issued to clients on Thursday morning, Credit Suisse reconfirmed their “Outperform” rating on Humana (NYSE:HUM) shares. They now have a $390 target price on the firm. Credit Suisse’s target indicates a potential upside of 14.84 % from the company’s close price.

Humana Inc. (NYSE:HUM) Ratings Coverage

Among 7 analysts covering Humana (NYSE:HUM), 6 have Buy rating, 0 Sell and 1 Hold. Therefore 86% are positive. Humana has $400 highest and $340 lowest target. $369.14’s average target is 8.70% above currents $339.59 stock price. Humana had 9 analyst reports since June 1, 2018 according to SRatingsIntel. As per Thursday, August 2, the company rating was maintained by Bank of America. The firm earned “Overweight” rating on Thursday, August 2 by Morgan Stanley. The firm earned “Outperform” rating on Monday, June 25 by BMO Capital Markets. Morgan Stanley maintained it with “Overweight” rating and $400 target in Wednesday, September 5 report. The stock has “Overweight” rating by Morgan Stanley on Thursday, July 12. The firm has “Buy” rating given on Thursday, August 2 by Jefferies. The firm has “Buy” rating given on Friday, June 1 by Citigroup.

The stock decreased 4.07% or $14.39 during the last trading session, reaching $339.59. About 1.07 million shares traded or 106.09% up from the average. Humana Inc. (NYSE:HUM) has risen 29.98% since November 9, 2017 and is uptrending. It has outperformed by 14.36% the S&P500.

Humana Inc., together with its subsidiaries, operates as a health and well-being firm in the United States. The company has market cap of $46.78 billion. The firm operates through three divisions: Retail, Group, and Healthcare Services. It has a 35.1 P/E ratio. The Retail segment offers Medicare benefits, as well as commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products directly to individuals or through group accounts.

More notable recent Humana Inc. (NYSE:HUM) news were published by: Nasdaq.com which released: “7 Healthcare Stocks Soaring on Election Results” on November 08, 2018, also Seekingalpha.com with their article: “Midterm Elections – Cramer’s Mad Money (11/6/18)” published on November 07, 2018, Benzinga.com published: “Earnings Scheduled For November 7, 2018” on November 07, 2018. More interesting news about Humana Inc. (NYSE:HUM) were released by: Streetinsider.com and their article: “Humana (HUM) Tops Q3 EPS by 32c; Raises FY18 EPS Guidance Above Consensus” published on November 07, 2018 as well as Nasdaq.com‘s news article titled: “Mid-Day Market Update: Crude Oil Down 1.3%; SendGrid Shares Spike Higher” with publication date: November 07, 2018.

Humana Inc. (NYSE:HUM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.